News FDA to review “missing” drug company documents BMJ 2004; 330 doi: https://doi.org/10.1136/bmj.330.7481.7 (Published 30 December 2004) Cite this as: BMJ 2004;330:7 Article Related content Metrics Responses Peer review Related articles Correction And Apology Eli Lilly: Correction and apology Published: 27 January 2005; BMJ 330 doi:10.1136/bmj.330.7485.211-a News Research confirms human to human transmission of avian flu Published: 27 January 2005; BMJ 330 doi:10.1136/bmj.330.7485.211 See more Demand for abortions surges as contraception services shrink and cost of living rises BMJ January 31, 2023, 380 p237; DOI: https://doi.org/10.1136/bmj.p237 Consultants in England to be balloted on industrial action next month BMJ January 31, 2023, 380 p234; DOI: https://doi.org/10.1136/bmj.p234 Brexit adds further complexity to the health and care staffing crisis BMJ January 31, 2023, 380 p208; DOI: https://doi.org/10.1136/bmj.p208 Brexit three years on: Health and the NHS are still suffering BMJ January 31, 2023, 380 p232; DOI: https://doi.org/10.1136/bmj.p232 NHS to fund extra beds and ambulances to tackle long emergency care waits BMJ January 30, 2023, 380 p239; DOI: https://doi.org/10.1136/bmj.p239 Cited by... Eli Lilly defends itself against assertions in BMJFulltext PDF
